价格

Esteve Pharmaceuticals S.A.

ACTIVE

西班牙www.esteve.comSubsidiary1,001–5,000 名员工成立于: 1929-01-01

隶属于 corporación químico farmaceútica esteve sa

概览

试验阶段分布

阶段

试验数

占比

1 期

50.0%

试验状态分布

进行中（未招募）

50.0%

招募中

50.0%

药物批准

按机构分类的批准

FDA

Food and Drug Administration

药物批准

EMA

European Medicines Agency

药物批准

CIMA_AEMPS

Spanish Agency for Medicines and Medical Devices

药物批准

近期批准

NULIVIOR 44 MG/56 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

CIMA_AEMPS

2026-04-30

METASEDIN 5 mg COMPRIMIDOS

CIMA_AEMPS

2025-07-14

METASEDIN 10 MG/ML SOLUCIÓN INYECTABLE

TOPIONIC 100 MG/ML SOLUCION CUTANEA

CIMA_AEMPS

2025-07-14

VELYNTRA 44 MG/56 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

CIMA_AEMPS

2023-09-25

XERISTAR 90 MG CAPSULAS DURAS GASTRORRESISTENTES

CIMA_AEMPS

2022-07-29

资讯

暂无资讯文章

返回机构列表

Esteve Pharmaceuticals S.A.

概览

试验阶段分布

试验状态分布

相关临床试验

该机构主办的试验（2）

Study to test the safety and the initial efficacy of an investigational medicinal product, abbreviated as AAV9-hSGSH, in children with Sanfilippo A Syndrom.

Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).

药物批准

按机构分类的批准

近期批准

资讯